Vaxcyte Inc
USUSDVaxcyte Inc (US:PCVX) — Biotechnology: Biological Products (No Diagnostic Substances). Брой борси, на които се търгуват акциите на компанията: 2. На тази страница — цена и график, дивиденти, най-големи акционери и история на броя на акциите.
За компанията
- Уебсайт
- vaxcyte.com
- Сектор
- Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
- Централа
- SAN CARLOS, United States
- Изпълнителен директор
- Mr. Grant E. Pickering M.B.A.
- Служители
- 507
- Акции в обращение
- 148.81 млн към 2026-08-03
- Свободно търгуеми акции
- 136.44 млн
- Пазарна капитализация
- 8.34 млрд USD
- Инсайдери
- 0.5%
- Институционални инвеститори
- 113.47%
- Отрасъл (SIC)
- Biological Products, (No Diagnostic Substances)
Описание
Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV for the prevention of IPD in adults and children; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting the keystone pathogen responsible for periodontitis; VAX-GI, a novel preclinical vaccine candidate for the treatment of dysentery and shigellosis, which is caused by Shigella bacteria; and VAX-XL, a third-generation pneumococcal conjugate vaccine. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
Дивиденти
Не са намерени дивидентни плащания (проверено 04.10.2026). Вероятно компанията не изплаща дивиденти.
Най-големи притежатели
| Притежател | Дял | Акции | Дата на доклада |
|---|---|---|---|
| FMR, LLC | 14.01% | 20.85 млн | 2026-06-30 |
| Jupiter Topco LLC | 12.07% | 17.97 млн | 2026-06-30 |
| T. Rowe Price Investment… | 8.2% | 12.21 млн | 2026-06-30 |
| Blackrock Inc. | 8.11% | 12.07 млн | 2026-06-30 |
| RA Capital Management, L… | 7.71% | 11.47 млн | 2026-06-30 |
| Wellington Management Gr… | 4.71% | 7 млн | 2026-06-30 |
| Vanguard Portfolio Manag… | 4.43% | 6.59 млн | 2026-06-30 |
| Vanguard Capital Managem… | 4.27% | 6.35 млн | 2026-06-30 |
| State Street Corporation | 3.6% | 5.35 млн | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.08% | 4.59 млн | 2026-06-30 |
| Deep Track Capital, Lp | 2.89% | 4.3 млн | 2026-06-30 |
| T. ROWE PRICE CAPITAL AP… | 2.69% | 4.01 млн | 2026-06-30 |
| iShares Trust-iShares Ru… | 2.27% | 3.37 млн | 2026-08-31 |
| VANGUARD INDEX FUNDS-Van… | 2.23% | 3.31 млн | 2026-06-30 |
| Fidelity Rutland Square… | 2.11% | 3.14 млн | 2026-07-31 |
| JANUS INVESTMENT FUND-Ja… | 1.8% | 2.68 млн | 2026-06-30 |
| VANGUARD SPECIALIZED FUN… | 1.57% | 2.34 млн | 2026-07-31 |
| SPDR SERIES TRUST-State… | 1.55% | 2.31 млн | 2026-08-31 |
| JANUS INVESTMENT FUND-Ja… | 1.53% | 2.27 млн | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 1.28% | 1.91 млн | 2026-06-30 |
| GUGGENHIME ANDREW (Presi… | ≈0.11% | 167 026 | 2026-08-03 |
| WASSIL JAMES (Chief Oper… | ≈0.1% | 145 435 | 2026-09-09 |
| DHALIWAL HARPREET S. (Of… | ≈0.05% | 76 756 | 2026-08-05 |
| JODAR LUIS (Officer) | ≈0.04% | 52 632 | 2026-09-04 |
| EYDELMAN MIKHAIL (Genera… | ≈0.03% | 41 620 | 2025-03-05 |
| COWAN ELVIA (Officer) | ≈0.02% | 28 975 | 2026-04-07 |
| LUKATCH HEATH SCOTT (Dir… | ≈0.01% | 19 481 | 2026-06-15 |
| LOXAM TERI (Director) | ≈0.01% | 12 481 | 2026-06-15 |
| PAYA CARLOS V (Director) | ≈0.01% | 12 481 | 2026-06-15 |
| PICKERING GRANT E (Chief… | — | — | 2026-07-27 |
Събития при регулатора
| Дата | Регулатор | Събитие | Подробности |
|---|---|---|---|
| 2026-10-02 | SEC | інсайдерська подача | Форма 4 |
